Bristol-Myers, Pfizer Win Fight Over Eliquis Patents
A Delaware federal judge on Wednesday upheld two patents held by Bristol-Myers Squibb, one jointly with Pfizer, that underlie their anticoagulant medication Eliquis, ruling that proposed drugs from Sigmapharm, Sunshine Lake...To view the full article, register now.
Already a subscriber? Click here to view full article